Investigator Site 111 — Dallas, Texas

Investigator Site 111 is a clinical research site located in Dallas, Texas, United States 75235.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 111 has participated in 3 clinical trials.

Therapeutic areas: Exocrine Pancreatic Insufficiency, Cystic Fibrosis.

Sponsors: Anthera Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 111?

Investigator Site 111 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 111 conducted?

Investigator Site 111 has 3 clinical trials on record. Their work covers Exocrine Pancreatic Insufficiency, Cystic Fibrosis.

Is Investigator Site 111 accredited by Crixeo Health?

Investigator Site 111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 111?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.